Genetic Technologies Ltd (GENE)
US37185R4065 - ADR
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.02M | 7.85M | 11.73M | 20.90M | 14.21M | |||
| Cash Equivalents | N/A | N/A | N/A | N/A | 14.21M | |||
| Marketable Securities | N/A | N/A | N/A | N/A | N/A | |||
| Receivables | 2.13M | 1.92M | 2.42M | 1.07M | 789.35K | |||
| Inventories | 206.47K | 325.89K | 398.15K | 76.93K | 91.39K | |||
| Other Current Assets | 341.75K | 399.05K | 166.08K | 182.58K | 97.85K | |||
| Total Current Assets | 3.70M | 10.50M | 14.72M | 22.24M | 15.19M | |||
| Non-Current Assets | ||||||||
| PPE Net | 264.49K | 599.18K | 953.33K | 637.71K | 440.23K | |||
| Investments And Advances | N/A | N/A | N/A | N/A | N/A | |||
| Goodwill | 1.78M | 3.12M | 4.51M | N/A | N/A | |||
| Intangibles | 360.06K | 520.47K | 624.92K | N/A | N/A | |||
| Other Non-Current Assets | 81.70K | 121.90K | 0.00 | 97.87K | 0.00 | |||
| Total Non-Current Assets | 2.49M | 4.36M | 6.08M | 735.58K | 440.23K | |||
| TOTAL ASSETS | 6.19M | 14.86M | 20.80M | 22.97M | 15.63M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 643.55K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 208.72K | 303.57K | 264.13K | 179.63K | 240.92K | |||
| Accrued Expenses | 858.34K | 1.07M | 1.47M | 464.77K | 432.93K | |||
| Accounts Payable | 3.49M | 837.95K | 1.15M | 760.35K | 723.72K | |||
| Other Current Liabilities | 1.03M | 1.10M | 920.82K | 465.41K | N/A | |||
| Total Current Liabilities | 4.20M | 3.31M | 3.81M | 1.41M | 1.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 22.92K | 229.28K | 388.40K | 24.41K | 240.87K | |||
| Deferred Taxes/Income | 81.70K | 121.90K | 148.01K | N/A | N/A | |||
| Other Non-Current Liabilities | 56.02K | 30.44K | 22.50K | 8.86K | 1.93K | |||
| Total Non-Current Liabilities | 160.65K | 381.61K | 558.91K | 33.27K | 242.80K | |||
| TOTAL LIABILITIES | 4.36M | 3.69M | 4.37M | 1.44M | 1.64M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -162.82M | -151.03M | -139.45M | -132.04M | -126.12M | |||
| Common Shares | 163.82M | 161.34M | 155.14M | 153.57M | 140.11M | |||
| Other Shareholders' Equity | 831.14K | 847.41K | 746.82K | N/A | N/A | |||
| Shares Outstanding | 2.99M | 2.61M | 2.09M | 2.04M | 162.32M | |||
| Tangible Book Value per Share | -0.00 | 0.06 | 0.12 | 0.23 | 0.00 | |||
| Total Shareholders' Equity | 1.83M | 11.16M | 16.43M | 21.53M | 13.99M | |||
| TOTAL LIABILITIES AND EQUITY | 6.19M | 14.86M | 20.80M | 22.97M | 15.63M | |||
| Statistics | ||||||||
| Debt/Equity | 0.36 | 0.02 | 0.02 | 0.00 | 0.02 | |||
| Current Ratio | 0.88 | 3.17 | 3.86 | 15.82 | 10.87 | |||
| Return On Assets (ROA) | -194.25% | -79.10% | -34.28% | -30.81% | -40.27% | |||
| Return On Equity (ROE) | -656.53% | -105.27% | -43.40% | -32.87% | -44.99% | |||
All data in AUD , ROIC based on taxRate of 0.21